Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

WHO Biowaiver Study Project for COVID-19 Outbreak: Dexamethasone Solubility Results for Biopharmaceutical Classification System.

Subjects: BIOAVAILABILITY; INTRAVENOUS therapy; MOLECULAR structure

  • Source: WHO Drug Information. 2020, Vol. 34 Issue 3, p466-471. 6p.

  • Abstract: The article offers information on the WHO Biowaiver Study Project for Covid-19 test with the use of Dexamethasone solubility. It discusses ...

Record details

×
Academic Journal

Proposed INN: List 124 -- COVID-19 (special edition).

Subjects: ANTIVIRAL agents; DRUGS; MOLECULAR structure

  • Source: WHO Drug Information. 2020, Vol. 34 Issue 3, p641-685. 45p.

  • Abstract: The article lists several international Nonproprietary Names for Pharmaceutical Substances (INN) in the impact of Covid-19 which includes abdavomeranum, alunacedase alfa ...

Record details

×
Academic Journal

WHO Biowaiver Project - Preparation for cycle IV (2021): Prioritization exercise of active pharmaceutical ingredients on the WHO Model List of Essential Medicines for solubility determination and Biopharmaceutics Classification System-based classification.

Subjects: CHLOROQUINE; DOSAGE forms of drugs; EMERGENCY medical services

  • Source: WHO Drug Information. 2020, Vol. 34 Issue 3, p485-491. 7p.

  • Abstract: The article offers study cycles on WHO Biowaiver Project and recommended continuing the Biopharmaceutics Classification System (BCS)-based classification of active pharmaceutical ingredients (APIs) contained ...

Record details

×
  • 1-3 of  3 results for "COVID-19"